(Q39001989)

8 September 2017

title

Interferon-alpha significantly reduces cerebrospinal fluid CD4 cell subsets in HAM/TSP. (English)

1 reference

8 September 2017

0 references

Juan Feng

1

1 reference

8 September 2017

Tatsuro Misu

2

1 reference

8 September 2017

Kazuo Fujihara

3

1 reference

8 September 2017

Hiroshi Saito

4

1 reference

8 September 2017

Toshiaki Takahashi

5

1 reference

8 September 2017

Takeshi Kohnosu

6

1 reference

8 September 2017

Yusei Shiga

7

1 reference

8 September 2017

Atsushi Takeda

8

1 reference

8 September 2017

Shigeru Sato

9

1 reference

8 September 2017

Sadao Takase

10

1 reference

8 September 2017

Yasuto Itoyama

11

1 reference

8 September 2017

publication date

1 August 2003

1 reference

Journal of Neuroimmunology

8 September 2017

published in

1 reference

8 September 2017

volume

141

1 reference

8 September 2017

issue

1-2

1 reference

8 September 2017

page(s)

170-173

1 reference

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900219-4

7 January 2021

Increases in helper inducer T cells and activated T cells in HTLV-I-associated myelopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900219-4

7 January 2021

Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900219-4

7 January 2021

Characterization of humoral and cellular immunity in the central nervous system of HAM/TSP.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900219-4

7 January 2021

A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900219-4

7 January 2021

Increased HTLV-I proviral load and preferential expansion of HTLV-I Tax-specific CD8+ T cells in cerebrospinal fluid from patients with HAM/TSP.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900219-4

7 January 2021

HTLV-I associated myelopathy, a new clinical entity.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900219-4

7 January 2021

Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900219-4

7 January 2021

Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900219-4

7 January 2021

Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virological and immunological study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900219-4

7 January 2021

Natural killer (NK) cells in HTLV-I-associated myelopathy/tropical spastic paraparesis-decrease in NK cell subset populations and activity in HTLV-I seropositive individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900219-4

7 January 2021

Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2803%2900219-4

7 January 2021

10.1016/S0165-5728(03)00219-4

Identifiers

DOI

1 reference

8 September 2017

1 reference